11 – 20 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries
(
- Contribution to journal › Article
-
Mark
PACAP and its role in primary headaches
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Differential inhibitory response to telcagepant on αCGRP induced vasorelaxation and intracellular Ca2+ levels in the perfused and non-perfused isolated rat middle cerebral artery
(
- Contribution to journal › Article
-
Mark
Level of physical activity, well-being, stress and self-rated health in persons with migraine and co-existing tension-type headache and neck pain
(
- Contribution to journal › Article
-
Mark
Topical dura mater application of CFA induces enhanced expression of c-fos and glutamate in rat trigeminal nucleus caudalis : attenuated by KYNA derivate (SZR72)
(
- Contribution to journal › Article
-
Mark
Blocking CGRP in migraine patients – a review of pros and cons
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Expression of messenger molecules and receptors in rat and human sphenopalatine ganglion indicating therapeutic targets
(
- Contribution to journal › Article
-
Mark
Release of PACAP-38 in episodic cluster headache patients - An exploratory study
(
- Contribution to journal › Article
-
Mark
KYNA analogue SZR72 modifies CFA-induced dural inflammation- regarding expression of pERK1/2 and IL-1β in the rat trigeminal ganglion
(
- Contribution to journal › Article
- 2015
-
Mark
Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study.
(
- Contribution to journal › Article